CSIMarket
 

Jounce Therapeutics inc   (NASDAQ: JNCE)

Jounce Therapeutics Inc 's

Competitiveness




 

JNCE Sales vs. its Competitors Q4 2022







Revenue Growth Comparisons




Net Income Comparison


Jounce Therapeutics inc recorded a net loss, as well as most of its competitors.

<<  JNCE Stock Performance Comparisons



*Market share is calculated based on total revenue.





Publicly Traded Peers of Jounce Therapeutics inc




Surface Oncology Inc
Share Performance



+33.75%
This Quarter



Surface Oncology Inc
Profile

Surface Oncology Inc is a biotechnology company focused on developing innovative immunotherapies to treat cancer. They employ a research-driven approach to identify and target novel immune checkpoints and design therapeutic antibodies to activate the immune system against tumors. Their business model revolves around conducting preclinical and clinical research, collaborating with strategic partners, and licensing or commercializing their products to bring new treatment options to patients.

More about Surface Oncology Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 64.968 mill. $ - mill. $ -92.505 mill.

Sources: Jounce Therapeutics inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Jounce Therapeutics inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.